AA
Anwar Ali Fathima Safrin
About Anwar Ali Fathima Safrin
Data last updated:
Anwar Ali Fathima Safrin is a Director at Well Worth Life Sciences Private Limited (since 2023). The company operates in Pharma. Well Worth Life Sciences Private Limited reported revenue of ₹25 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Well Worth Life Sciences Private Limited U51909TN2014PTC095430 | Director | 04 May 2023 | 2014 | ₹25 Lakh (FY 2024) | Active |
Board colleagues of Anwar Ali Fathima Safrin
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohamed Yasar Arafath | 06824257 | Well Worth Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anwar Ali Fathima Safrin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anwar Ali Fathima Safrin
Anwar Ali Fathima Safrin currently holds 1 directorship: Well Worth Life Sciences Private Limited (Director, since 04 May 2023, revenue ₹25 Lakh (FY 2024)).
Anwar Ali Fathima Safrin was first appointed on 04 May 2023 as Director at Well Worth Life Sciences Private Limited.
The current boards of Anwar Ali Fathima Safrin's companies include Mohamed Yasar Arafath (Well Worth Life Sciences Private Limited).